1
2
3
4
Quist, S. W., Postma, A. J., Myrén, K. J., de Jong, L. A., Postma, M. J.
Veröffentlicht in: Quist , S W , Postma , A J , Myrén , K J , de Jong , L A & Postma , M J 2023 , ' Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands ' , European Journal of Health Economics . https://doi.org/10.1007/s10198-022-01556-5;
2023
Veröffentlicht in: Quist , S W , Postma , A J , Myrén , K J , de Jong , L A & Postma , M J 2023 , ' Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands ' , European Journal of Health Economics . https://doi.org/10.1007/s10198-022-01556-5;
2023
5
6
7
8
9
10
van Baal, Pieter H. M., Feenstra, Talitha L., Polder, Johan J., Hoogenveen, Rudolf T., Brouwer, Werner B. F.
Veröffentlicht in: van Baal , P H M , Feenstra , T L , Polder , J J , Hoogenveen , R T & Brouwer , W B F 2011 , ' ECONOMIC EVALUATION AND THE POSTPONEMENT OF HEALTH CARE COSTS ' , Health Economics , vol. 20 , no. 4 , pp. 432-445 . https://doi.org/10.1002/hec.1599;
2011
Veröffentlicht in: van Baal , P H M , Feenstra , T L , Polder , J J , Hoogenveen , R T & Brouwer , W B F 2011 , ' ECONOMIC EVALUATION AND THE POSTPONEMENT OF HEALTH CARE COSTS ' , Health Economics , vol. 20 , no. 4 , pp. 432-445 . https://doi.org/10.1002/hec.1599;
2011